Healthcare

The move comes amid a broader session that has seen mixed performance across the Australian market, with the healthcare sector drawing particular investor attention. Nanollose Ltd's 7.58% move reflects the intersection of company-specific developments, sector dynamics, and prevailing market sentiment.

Algorae Pharmaceuticals Ltd (ASX:1AI) is making headlines on theAustralian Securities Exchangetoday, with its share price rising 7.14% to $0.015 on March 13, 2026. The stock recorded $4,519 in turnover, placing it among the most actively traded gainers on theASXin today's session.

Recce Pharmaceuticals Ltd (ASX:RCE) is making headlines on theAustralian Securities Exchangetoday, with its share price rising 5.62% to $0.48 on March 13, 2026. The stock recorded $18,988 in turnover, placing it among the most actively traded gainers on the ASX in today's session.

RHYTHM Biosciences Ltd (ASX:RHY) is making headlines on theAustralian Securities Exchangetoday, with its share price rising 7.50% to $0.215 on March 13, 2026. The stock recorded $101,129 in turnover, placing it among the most actively traded gainers on the ASX in today's session.

Ebos Group operates through two primary segments: Healthcare and Animal Care, serving patients, healthcare providers, and veterinary clinicians across Australia, New Zealand, and Southeast Asia. The Healthcare segment distributes pharmaceuticals, medical devices, and healthcare products to hospitals, general practitioners, pharmacies, and aged care facilities. …

The challenge facing Epiminder is a classic biotech story: a pre-revenuecompany with a genuinely innovative FDA-approved product, burning through capital at an alarming rate, and facing significant execution risk in commercialization. The $34.5M loss in FY25—up 54% from prior year—reflects the massive R&D and …

While ACL maintains a respectable market position with high-teens share of the pathology market, it faces structural challenges from fixed Medicare fee schedules, declining GP-referred volumes, and increased competitive pressures. However, recent operational improvements and strategic initiatives suggest the company may be finding pathways …